Skip to main content

Advertisement

Log in

The use of botulinum neurotoxin type A (BoNTA) in urology

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

The use of Botulinum neurotoxin type A (BoNT/A) in the lower urinary tract was pioneered as early as 20 years ago with injections into the urethral sphincter reducing bladder voiding pressures, urethral pressures, and post-void residual urine. Over the past 9 years, the use of BoNT/A has revolutionised the treatment of intractable symptoms associated with the neurogenic or idiopathic overactive bladder, both in adults and children. The duration of clinical improvement is 6–11 months, is accompanied by significant amelioration of patients’ quality of life and repeat bladder treatments appear to have sustained effects. Despite evidence for an effect on the afferent pathways, its mode of action in the human bladder remains largely unknown. The use of BoNT/A has also expanded into the painful bladder syndrome and in benign prostatic diseases, with promising preliminary results.

This review aims to provide an insight of the use of BoNT/A in the lower urinary tract, addressing issues such as treatment outcomes and safety, mechanisms of action and potential for future research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • P Abrams L Cardozo M Fall D Griffiths P Rosier U Ulmsten P van Kerrebroeck A Victor A Wein (2002) ArticleTitleThe standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 167–178 Occurrence Handle11857671

    PubMed  Google Scholar 

  • A Apostolidis CM Brady Y Yiangou J Davis CJ Fowler P Anand (2005a) ArticleTitleCapsaicin receptor TRPV1 in the urothelium of neurogenic human bladders and the effect of intravesical resiniferatoxin Urology 65 400–405

    Google Scholar 

  • A Apostolidis P Dasgupta CJ Fowler (2006a) ArticleTitleProposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity Eur Urol 49 IssueID4 644–650 Occurrence Handle1:CAS:528:DC%2BD28XkvVansr0%3D

    CAS  Google Scholar 

  • A Apostolidis TS Jacques A Freeman S Ghazi-Noori V Kalsi R Popat G Gonzales A Beckett S Datta S Elneil P Dasgupta CJ Fowler (2006b) ArticleTitleHistological changes in the human bladder urothelium and suburothelium following injections of botulinum neurotoxin type A (BoNT/A) for the treatment of neurogenic versus idiopathic detrusor overactivity (NDO/IDO) Neurourol Urodyn 25 IssueID6 661–662

    Google Scholar 

  • A Apostolidis R Popat Y Yiangou D Cockayne AP Ford JB Davis P Dasgupta CJ Fowler P Anand (2005b) ArticleTitleDecreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity J Urol 174 IssueID3 977–983 Occurrence Handle1:CAS:528:DC%2BD2MXnt1yrsr0%3D

    CAS  Google Scholar 

  • A Apostolidis R Popat Y Yiangou CJ Fowler P Dasgupta P Anand (2004) ArticleTitleSuccessful clinical outcome of intra-detrusor botulinum toxin for human detrusor overactivity is not associated with suburothelial neuronal or cholinergic fibre degeneration or sprouting J Endourol 18 IssueIDSuppl 1 A108

    Google Scholar 

  • LA Birder AJ Kanai WC de Groat S Kiss ML Nealen NE Burke KE Dineley S Watkins IJ Reynolds MJ Caterina (2001) ArticleTitleVanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells Proc Natl Acad Sci USA 98 IssueID23 13396–13401 Occurrence Handle11606761 Occurrence Handle1:CAS:528:DC%2BD3MXosFygtbY%3D

    PubMed  CAS  Google Scholar 

  • LA Birder Y Nakamura S Kiss ML Nealen S Barrick AJ Kanai E Wang G Ruiz WC De Groat G Apodaca S Watkins MJ Caterina (2002) ArticleTitleAltered urinary bladder function in mice lacking the vanilloid receptor TRPV1 Nat Neurosci 5 IssueID9 856–860 Occurrence Handle12161756 Occurrence Handle1:CAS:528:DC%2BD38Xms1Wqt7g%3D

    PubMed  CAS  Google Scholar 

  • C Brady A Apostolidis Y Yiangou PA Baecker AP Ford CJ Fowler P Anand (2004a) ArticleTitleP2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin (RTX) Eur Urol 46 247–253 Occurrence Handle1:CAS:528:DC%2BD2cXmvVWrur8%3D

    CAS  Google Scholar 

  • CM Brady A Apostolidis M Harper Y Yiangou A Beckett TS Jacques A Freeman F Scaravilli CJ Fowler P Anand (2004b) ArticleTitleParallel changes in bladder suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical resiniferatoxin treatment BJU Int 93 770–776 Occurrence Handle1:CAS:528:DC%2BD2cXktlalsrw%3D

    CAS  Google Scholar 

  • G Burnstock (2001) ArticleTitlePurine-mediated signalling in pain and visceral perception Trends Pharmacol Sci 22 182–188 Occurrence Handle11282418 Occurrence Handle1:CAS:528:DC%2BD3MXit1Wnsbk%3D

    PubMed  CAS  Google Scholar 

  • E Chartier-Castler Y Igawa A Kovindha P Radziszewski A Stone P Wiesel D Castro H Madersbacher JJ Wyndaele (2005) Neurologic urinary and faecal incontinence P Abrams L Cardozo S Khoury A Wein (Eds) Incontinence NumberInSeries2 Health Publications Ltd. Paris 1059–1162

    Google Scholar 

  • YC Chuang PH Chiang CC Huang N Yoshimura MB Chancellor (2005) ArticleTitleBotulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates Urology 66 IssueID4 775–779 Occurrence Handle16230137

    PubMed  Google Scholar 

  • YC Chuang PH Chiang N Yoshimura F De Miguel MB Chancellor (2006a) ArticleTitleSustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia BJU Int 98 IssueID5 1033–1037 Occurrence Handle1:CAS:528:DC%2BD28Xhtlagu7nI

    CAS  Google Scholar 

  • YC Chuang CC Huang HY Kang PH Chiang F Demiguel N Yoshimura MB Chancellor (2006b) ArticleTitleNovel action of botulinum toxin on the stromal and epithelial components of the prostate gland J Urol 175 IssueID3 Pt 1 1158–1163 Occurrence Handle1:CAS:528:DC%2BD28XitFSit7s%3D

    CAS  Google Scholar 

  • YC Chuang CH Tu CC Huang HJ Lin PH Chiang N Yoshimura MB Chancellor (2006c) ArticleTitleIntraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs BMC Urol 6 12

    Google Scholar 

  • YC Chuang N Yoshimura CC Huang PH Chiang MB Chancellor (2004) ArticleTitleIntravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats J Urol 172 IssueID4 Pt 1 1529–1532 Occurrence Handle15371885 Occurrence Handle1:CAS:528:DC%2BD2cXnsFejtr0%3D

    PubMed  CAS  Google Scholar 

  • YC Chuang N Yoshimura M Wu CC Huang PH Chiang P Tyagi MB Chancellor (2006d) ArticleTitleIntraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A Eur Urol 51 1119–1127

    Google Scholar 

  • DA Cockayne SG Hamilton Q-M Zhu PM Dunn Y Zhong S Novakovic AB Malmberg G Cain A Berson L Kassotakis L Hedley WG Lachnit G Burnstock SB McMahon AP Ford (2000) ArticleTitleUrinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice Nature 407 1011–1015 Occurrence Handle11069181 Occurrence Handle1:CAS:528:DC%2BD3cXnvVaqsLk%3D

    PubMed  CAS  Google Scholar 

  • E Comperat A Reitz A Delcourt F Capron P Denys E Chartier-Kastler (2006) ArticleTitleHistologic features in the urinary bladder wall affected from neurogenic overactivity – a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A Eur Urol 50 1058–1064 Occurrence Handle16517054 Occurrence Handle1:CAS:528:DC%2BD28Xht1erurzJ

    PubMed  CAS  Google Scholar 

  • M Cui S Khanijou J Rubino KR Aoki (2004) ArticleTitleSubcutaneous administration of botulinum toxin A reduces formalin-induced pain Pain 107 125–133 Occurrence Handle14715398 Occurrence Handle1:CAS:528:DC%2BD2cXjsFSksA%3D%3D

    PubMed  CAS  Google Scholar 

  • K De Laet JJ Wyndaele (2005) ArticleTitleAdverse events after botulinum A toxin injection for neurogenic voiding disorders Spinal Cord 43 IssueID7 397–399 Occurrence Handle15741978 Occurrence Handle1:STN:280:DC%2BD2MzksVagsQ%3D%3D

    PubMed  CAS  Google Scholar 

  • M de Seze H Petit P Gallien MP de Seze PA Joseph JM Mazaux M Barat (2002) ArticleTitleBotulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease Eur Urol 42 IssueID1 56–62 Occurrence Handle12121731 Occurrence Handle1:CAS:528:DC%2BD38XntVyjsLg%3D

    PubMed  CAS  Google Scholar 

  • M de Seze L Wiart PA Joseph JP Dosque JM Mazaux M Barat (1998) ArticleTitleCapsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions Neurourol Urodyn 17 IssueID5 513–523 Occurrence Handle9776014 Occurrence Handle1:CAS:528:DyaK1cXmslCgt7k%3D

    PubMed  CAS  Google Scholar 

  • R Doggweiler DH Zermann M Ishigooka RA Schmidt (1998) ArticleTitleBotox-induced prostatic involution Prostate 37 IssueID1 44–50 Occurrence Handle9721068 Occurrence Handle1:CAS:528:DyaK1cXlslemtbc%3D

    PubMed  CAS  Google Scholar 

  • O Dolly (2003) ArticleTitleSynaptic transmission: inhibition of neurotransmitter release by botulinum toxins Headache 43 IssueIDSuppl 1 S16–S24 Occurrence Handle12887390

    PubMed  Google Scholar 

  • MJ Duggan CP Quinn JA Chaddock JR Purkiss FC Alexander S Doward SJ Fooks LM Friis YH Hall ER Kirby N Leeds HJ Moulsdale A Dickenson GM Green W Rahman R Suzuki CC Shone KA Foster (2002) ArticleTitleInhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin J Biol Chem 277 34846–34852 Occurrence Handle12105193 Occurrence Handle1:CAS:528:DC%2BD38Xnt1Wht7w%3D

    PubMed  CAS  Google Scholar 

  • D Dykstra A Enriquez M Valley (2003a) ArticleTitleTreatment of overactive bladder with botulinum toxin type B: a pilot study Int Urogynecol J Pelvic Floor Dysfunct 14 IssueID6 424–426

    Google Scholar 

  • DD Dykstra J Pryor G Goldish (2003b) ArticleTitleUse of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report Arch Phys Med Rehabil 84 IssueID9 1399–1400

    Google Scholar 

  • DD Dykstra AA Sidi (1990) ArticleTitleTreatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study Arch Phys Med Rehabil 71 IssueID1 24–26 Occurrence Handle2297305 Occurrence Handle1:STN:280:DyaK3c7itV2gsQ%3D%3D

    PubMed  CAS  Google Scholar 

  • DD Dykstra AA Sidi AB Scott JM Pagel GD Goldish (1988) ArticleTitleEffects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients J Urol 139 IssueID5 919–922 Occurrence Handle3361663 Occurrence Handle1:STN:280:DyaL1c3gtVClug%3D%3D

    PubMed  CAS  Google Scholar 

  • S Elneil JN Skepper EJ Kidd JG Williamson D Ferguson (2001) ArticleTitleDistribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladder Pharmacology 63 IssueID2 120–128 Occurrence Handle11490205 Occurrence Handle1:CAS:528:DC%2BD3MXmsVeht7o%3D

    PubMed  CAS  Google Scholar 

  • DR Ferguson I Kennedy T Burton (1997) ArticleTitleATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes – a possible sensory mechanism? J Physiol 505 503–511 Occurrence Handle9423189 Occurrence Handle1:CAS:528:DyaK1cXmtFOr

    PubMed  CAS  Google Scholar 

  • CJ Fowler CD Betts TJ Christmas M Swash CG Fowler (1992) ArticleTitleBotulinum toxin in the treatment of chronic urinary retention in women Br J Urol 70 IssueID4 387–389 Occurrence Handle1450846 Occurrence Handle1:STN:280:DyaK3s%2Fot1entQ%3D%3D Occurrence Handle10.1111/j.1464-410X.1992.tb15793.x

    Article  PubMed  CAS  Google Scholar 

  • P Gallien JM Reymann G Amarenco B Nicolas M de Seze E Bellissant (2005) ArticleTitlePlacebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients J Neurol Neurosurg Psychiatry 76 IssueID12 1670–1676 Occurrence Handle16291892 Occurrence Handle1:STN:280:DC%2BD2MnjsVKmsA%3D%3D

    PubMed  CAS  Google Scholar 

  • M Ghei BH Maraj R Miller S Nathan C O’Sullivan CJ Fowler PJ Shah J Malone-Lee (2005) ArticleTitleEffects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial J Urol 174 IssueID5 1873–1877 Occurrence Handle16217327 Occurrence Handle1:STN:280:DC%2BD2Mrlt1OksA%3D%3D

    PubMed  CAS  Google Scholar 

  • A Giannantoni E Costantini SM Di Stasi MC Tascini V Bini M Porena (2006a) ArticleTitleBotulinum a toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study Eur Urol 49 IssueID4 704–709 Occurrence Handle1:CAS:528:DC%2BD28XkvVansrc%3D

    CAS  Google Scholar 

  • A Giannantoni SM Di Stasi RL Stephen V Bini E Costantini M Porena (2004) ArticleTitleIntravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study J Urol 172 IssueID1 240–243 Occurrence Handle15201783 Occurrence Handle1:CAS:528:DC%2BD2cXksl2gtbk%3D

    PubMed  CAS  Google Scholar 

  • A Giannantoni SM Di Stasi V Nardicchi A Zucchi L Macchioni V Bini G Goracci M Porena (2006b) ArticleTitleBotulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity J Urol 175 2341–2344 Occurrence Handle1:CAS:528:DC%2BD28XlsVehtb0%3D

    CAS  Google Scholar 

  • JI Gillespie (2005) ArticleTitleInhibitory actions of calcitonin gene-related peptide and capsaicin: evidence for local axonal reflexes in the bladder wall BJU Int 95 149–156 Occurrence Handle15638914 Occurrence Handle1:CAS:528:DC%2BD2MXht1KmsL8%3D

    PubMed  CAS  Google Scholar 

  • TJ Greenwell SN Venn AR Mundy (2001) ArticleTitleAugmentation cystoplasty BJU Int 88 511–525 Occurrence Handle11678743 Occurrence Handle1:STN:280:DC%2BD3MrntVKnsg%3D%3D

    PubMed  CAS  Google Scholar 

  • J Grosse G Kramer M Stohrer (2005) ArticleTitleSuccess of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence Eur Urol 47 IssueID5 653–659 Occurrence Handle15826758 Occurrence Handle1:CAS:528:DC%2BD2MXksFWku7Y%3D

    PubMed  CAS  Google Scholar 

  • A Haferkamp B Schurch A Reitz U Krengel J Grosse G Kramer S Schumacher PJ Bastian R Buttner SC Muller M Stohrer (2004) ArticleTitleLack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder Eur Urol 46 784–791 Occurrence Handle15548448 Occurrence Handle1:STN:280:DC%2BD2crnvFenug%3D%3D

    PubMed  CAS  Google Scholar 

  • C Hampel R Gillitzer S Pahernik M Hohenfellner JW Thuroff (2003) ArticleTitle[Epidemiology and etiology of overactive bladder] Urologe A 42 IssueID6 776–786 Occurrence Handle12851768 Occurrence Handle1:STN:280:DC%2BD3szit1ahtQ%3D%3D

    PubMed  CAS  Google Scholar 

  • P Hoebeke K De Caestecker J Vande Walle J Dehoorne A Raes P Verleyen E Van Laecke (2006) ArticleTitleThe effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor J Urol 176 IssueID1 328–330 Occurrence Handle16753434 Occurrence Handle1:STN:280:DC%2BD28zktFeqtw%3D%3D

    PubMed  CAS  Google Scholar 

  • V Kalsi A Apostolidis G Gonzales S Elneil P Dasgupta CJ Fowler (2006a) ArticleTitleThe decline of urgency following intradetrusor botulinum neurotoxin type A (BoNT/A) injections for detrusor overactivity (DO): preliminary results Eur Urol 49 IssueIDSuppl 1 A798

    Google Scholar 

  • V Kalsi A Apostolidis R Popat G Gonzales CJ Fowler P Dasgupta (2006b) ArticleTitleQuality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes Eur Urol 49 IssueID3 528–535

    Google Scholar 

  • V Kalsi RB Popat A Apostolidis R Kavia IA Odeyemi HA Dakin J Warner S Elneil CJ Fowler P Dasgupta (2006c) ArticleTitleCost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre Eur Urol 49 IssueID3 519–527 Occurrence Handle1:CAS:528:DC%2BD28XkvVagu7Y%3D

    CAS  Google Scholar 

  • G Karsenty A Reitz G Lindemann S Boy B Schurch (2006) ArticleTitlePersistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity Urology 68 IssueID6 1193–1197 Occurrence Handle17141831

    PubMed  Google Scholar 

  • TM Kessler H Danuser M Schumacher UE Studer FC Burkhard (2005) ArticleTitleBotulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 24 IssueID3 231–236 Occurrence Handle15747344 Occurrence Handle1:CAS:528:DC%2BD2MXkvFyqsb4%3D

    PubMed  CAS  Google Scholar 

  • M Khera GT Somogyi S Kiss TB Boone CP Smith (2004) ArticleTitleBotulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury Neurochem Int 45 987–993 Occurrence Handle15337297 Occurrence Handle1:CAS:528:DC%2BD2cXntFSmsLY%3D

    PubMed  CAS  Google Scholar 

  • H Kuo (2005a) ArticleTitlePreliminary results of suburothelial injection of botulinum A toxin in the treatment of chronic interstitial cystitis Urologia Int 75 170–174 Occurrence Handle1:CAS:528:DC%2BD2MXpsFWjtbc%3D

    CAS  Google Scholar 

  • HC Kuo (2004) ArticleTitleUrodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents Urology 63 IssueID5 868–872 Occurrence Handle15134967

    PubMed  Google Scholar 

  • HC Kuo (2005b) ArticleTitleClinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics Urology 66 IssueID1 94–98

    Google Scholar 

  • HC Kuo (2005c) ArticleTitleEffectiveness of urethral injection of botulinum A toxin in the treatment of voiding dysfunction after radical hysterectomy Urol Int 75 IssueID3 247–251 Occurrence Handle1:CAS:528:DC%2BD2MXhtVyksL3O

    CAS  Google Scholar 

  • HC Kuo (2006a) ArticleTitleTherapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions Urology 67 IssueID2 232–236

    Google Scholar 

  • HC Kuo (2006b) ArticleTitleWill suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity? Urology 68 IssueID5 993–997

    Google Scholar 

  • Larson TR, Scottsdale AZ, Huidobro C, Acevedo C (2005) Intraprostatic injection of botulinum toxin in the treatment of symptomatic LUTS, including sequential MRIS for accurate changes in size of the prostate. J Urol (Suppl 173): 376 (abstr 1386)

  • M Lazzeri G Vannucchi C Zardo M Spinelli P Beneforti D Turini MS Pellegrini Faussone (2004) ArticleTitleImmunohistochemical evidence of vanilloid receptor 1 in normal human urinary bladder urothelium Eur Urol 46 792–799 Occurrence Handle15548449 Occurrence Handle1:CAS:528:DC%2BD2cXhtFGmsL%2FK

    PubMed  CAS  Google Scholar 

  • A Lecci CA Maggi (2001) ArticleTitleTachykinins as modulators of the micturition reflex in the central and peripheral nervous sytem Regul Pept 101 1–18 Occurrence Handle11495674 Occurrence Handle1:CAS:528:DC%2BD3MXlslGgs7g%3D

    PubMed  CAS  Google Scholar 

  • Liu H, Kuo H (2004) Clinical effectiveness of suburothelial injection of botulinum A toxin in the treatment of refractory detrusor overactivity. Meeting Proc., Int Continence Society 2004 Annual Meeting, Paris

  • EM Lowe P Anand G Terenghi RE Williams-Chestnut DV Sinicropi JL Osborne (1997) ArticleTitleIncreased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis Br J Urol 79 572–577 Occurrence Handle9126085 Occurrence Handle1:STN:280:DyaK2s3ntFWgtg%3D%3D

    PubMed  CAS  Google Scholar 

  • G Maria G Brisinda IM Civello AR Bentivoglio G Sganga A Albanese (2003) ArticleTitleRelief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study Urology 62 IssueID2 259–264 Occurrence Handle12893330

    PubMed  Google Scholar 

  • I Mokhless S Gaafar K Fouda M Shafik A Assem (2006) ArticleTitleBotulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder J Urol 176 IssueID4 Pt 2 1767–1770 Occurrence Handle16945643 Occurrence Handle1:CAS:528:DC%2BD28XhtVGitrnM

    PubMed  CAS  Google Scholar 

  • A Moon (2002) ArticleTitleInfluence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro BJU Int 89 942–949 Occurrence Handle12010245 Occurrence Handle1:CAS:528:DC%2BD38XltFamt7k%3D

    PubMed  CAS  Google Scholar 

  • C Morenilla-Palao R Planells-Cases N Garcia-Sanz A Ferrer-Montiel (2004) ArticleTitleRegulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity J Biol Chem 279 25665–25672 Occurrence Handle15066994 Occurrence Handle1:CAS:528:DC%2BD2cXksFygt7s%3D

    PubMed  CAS  Google Scholar 

  • G Mukerji Y Yiangou J Grogono J Underwood SK Agarwal V Khullar P Anand (2006) ArticleTitleLocalization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations J Urol 176 IssueID1 367–373 Occurrence Handle16753445 Occurrence Handle1:CAS:528:DC%2BD28XmvVKrtLc%3D

    PubMed  CAS  Google Scholar 

  • X Pang J Marchand GR Sant RM Kream TC Theoharides (1995) ArticleTitleIncreased number of substance P positive nerve fibres in interstitial cystitis Br J Urol 75 IssueID6 744–750 Occurrence Handle7542136 Occurrence Handle1:STN:280:DyaK2MzjvVGlsg%3D%3D

    PubMed  CAS  Google Scholar 

  • DS Park TW Cho YK Lee YT Lee YK Hong WK Jang (2006) ArticleTitleEvaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia Yonsei Med J 47 IssueID5 706–714 Occurrence Handle17066515

    PubMed  Google Scholar 

  • CL Parsons (2005) ArticleTitleSuccessful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis Urology 65 IssueID1 45–48 Occurrence Handle15667861

    PubMed  Google Scholar 

  • T Petersen JB Nielsen HD Schroder (1999) ArticleTitleIntravesical capsaicin in patients with detrusor hyperreflexia – a placebo-controlled cross-over study Scand J Urol Nephrol 33 104–110 Occurrence Handle10360450 Occurrence Handle1:CAS:528:DyaK1MXksVyjsLw%3D

    PubMed  CAS  Google Scholar 

  • R Popat A Apostolidis V Kalsi G Gonzales CJ Fowler P Dasgupta (2005) ArticleTitleA comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin J Urol 174 IssueID3 984–988 Occurrence Handle16094019 Occurrence Handle1:CAS:528:DC%2BD2MXnt1yrsro%3D

    PubMed  CAS  Google Scholar 

  • ZI Radojicic SV Perovic NM Milic (2006) ArticleTitleIs it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin? J Urol 176 IssueID1 332–336 Occurrence Handle16753436

    PubMed  Google Scholar 

  • GN Rajkumar DR Small AW Mustafa G Conn (2005) ArticleTitleA prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity BJU Int 96 IssueID6 848–852 Occurrence Handle16153215 Occurrence Handle1:CAS:528:DC%2BD2MXhtFGrt7zJ

    PubMed  CAS  Google Scholar 

  • DE Rapp A Lucioni EE Katz RC O’Connor GS Gerber GT Bales (2004) ArticleTitleUse of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience Urology 63 1071–1075 Occurrence Handle15183952

    PubMed  Google Scholar 

  • DE Rapp KW Turk GT Bales SP Cook (2006) ArticleTitleBotulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder J Urol 175 IssueID3 Pt 1 1138–1142 Occurrence Handle16469640 Occurrence Handle1:CAS:528:DC%2BD28XitFSit7w%3D

    PubMed  CAS  Google Scholar 

  • A Reitz B Schurch (2004) ArticleTitleBotulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity J Urol 171 IssueID2 Pt 1 804 Occurrence Handle14713822

    PubMed  Google Scholar 

  • A Reitz M Stohrer G Kramer G Del Popolo E Chartier-Kastler J Pannek H Burgdorfer K Gocking H Madersbacher S Schumacher R Richter J Von Tobel B Schurch (2004) ArticleTitleEuropean experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity Eur Urol 45 510–515 Occurrence Handle15041117 Occurrence Handle1:CAS:528:DC%2BD2cXjtlKit74%3D

    PubMed  CAS  Google Scholar 

  • M Riccabona M Koen M Schindler B Goedele A Pycha L Lusuardi SB Bauer (2004) ArticleTitleBotulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia J Urol 171 IssueID2 Pt 1 845–848 Occurrence Handle14713840 Occurrence Handle1:CAS:528:DC%2BD2cXisV2lsQ%3D%3D

    PubMed  CAS  Google Scholar 

  • D Rivas P Shenot K Stuliglowa (1999) ArticleTitleIntravesical resiniferatoxin treatment of detrusor hyperreflexia: results of a randomized, double-blind, placebo-controlled multicenter trial J Urol 161 276

    Google Scholar 

  • JR Roppolo C Tai AM Booth CA Buffington WC de Groat LA Birder (2005) ArticleTitleBladder adelta afferent nerve activity in normal cats and cats with feline interstitial cystitis J Urol 173 IssueID3 1011–1015 Occurrence Handle15711367

    PubMed  Google Scholar 

  • A Ruffion O Capelle P Paparel B Leriche A Leriche P Grise (2006) ArticleTitleWhat is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity? BJU Int 97 IssueID5 1030–1034 Occurrence Handle16643486 Occurrence Handle1:CAS:528:DC%2BD28XlsVCgtbk%3D

    PubMed  CAS  Google Scholar 

  • A Sahai S Khan P Dasgupta (2007) ArticleTitleEfficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single-center, randomised, double blind, placebo controlled trial J Urol 177 2231–2236 Occurrence Handle17509328 Occurrence Handle1:CAS:528:DC%2BD2sXmslKlu7k%3D

    PubMed  CAS  Google Scholar 

  • A Sahai S Khan P Dasgupta (2006) ArticleTitleQuality of life in patients with symptoms of overactive bladder and refractory idiopathic detrusor over activity following intradetrusor injections of botulinum toxin type A: results from a randomised, double blind, placebo-controlled trial Eur Urol 49 IssueID4 Suppl 1

    Google Scholar 

  • DM Schmid P Sauermann M Werner B Schuessler N Blick M Muentener RT Strebel D Perucchini D Scheiner G Schaer H John A Reitz D Hauri B Schurch (2006) ArticleTitleExperience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics J Urol 176 IssueID1 177–185 Occurrence Handle16753396 Occurrence Handle1:CAS:528:DC%2BD28XmvVKrtLg%3D

    PubMed  CAS  Google Scholar 

  • H Schulte-Baukloh HH Knispel T Stolze C Weiss T Michael K Miller (2005a) ArticleTitleRepeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity Urology 66 IssueID4 865–870

    Google Scholar 

  • H Schulte-Baukloh T Michael J Schobert T Stolze HH Knispel (2002) ArticleTitleEfficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results Urology 59 IssueID3 325–327 Occurrence Handle11880062 Occurrence Handle1:STN:280:DC%2BD387kvFyitg%3D%3D

    PubMed  CAS  Google Scholar 

  • H Schulte-Baukloh J Schobert T Stolze B Sturzebecher C Weiss HH Knispel (2006) ArticleTitleEfficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis Neurourol Urodyn 25 IssueID2 110–115 Occurrence Handle16470519 Occurrence Handle1:CAS:528:DC%2BD28XjsVyis7k%3D

    PubMed  CAS  Google Scholar 

  • H Schulte-Baukloh C Weiss T Stolze J Herholz B Sturzebecher K Miller HH Knispel (2005b) ArticleTitleBotulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction Eur Urol 48 IssueID6 984–990

    Google Scholar 

  • B Schurch D Hauri B Rodic A Curt M Meyer AB Rossier (1996) ArticleTitleBotulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients J Urol 155 1023–1029 Occurrence Handle8583552 Occurrence Handle1:CAS:528:DyaK28XksFSjtL8%3D

    PubMed  CAS  Google Scholar 

  • B Schurch J Hodler B Rodic (1997) ArticleTitleBotulinum A toxin as a treatment of detrusor-sphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injections J Neurol Neurosurg Psychiatry 63 474–476 Occurrence Handle9343126 Occurrence Handle1:STN:280:DyaK1c%2FgtFaqsw%3D%3D

    PubMed  CAS  Google Scholar 

  • B Schurch M Stohrer G Kramer DM Schmid G Gaul D Hauri (2000) ArticleTitleBotulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results J Urol 164 IssueID3 Pt 1 692–697 Occurrence Handle10953127 Occurrence Handle1:CAS:528:DC%2BD3cXmtlSmsb0%3D

    PubMed  CAS  Google Scholar 

  • B Schurch M de Seze P Denys E Chartier-Kastler F Haab K Everaert P Plante B Perrouin-Verbe C Kumar S Fraczek MF Brin (2005) ArticleTitleBotulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study J Urol 174 IssueID1 196–200 Occurrence Handle15947626 Occurrence Handle1:CAS:528:DC%2BD2MXkvFSqtbg%3D

    PubMed  CAS  Google Scholar 

  • C Silva J Silva MJ Ribeiro A Avelino F Cruz (2005) ArticleTitleUrodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial Eur Urol 48 IssueID4 650–655 Occurrence Handle15961217 Occurrence Handle1:CAS:528:DC%2BD2MXhtFKnsrnP

    PubMed  CAS  Google Scholar 

  • PJ Smet KH Moore J Jonavicius (1997) ArticleTitleDistribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder Lab Invest 77 37–49 Occurrence Handle9251677 Occurrence Handle1:CAS:528:DyaK2sXls1Sqtr8%3D

    PubMed  CAS  Google Scholar 

  • CP Smith J Nishiguchi M O’Leary N Yoshimura MB Chancellor (2005) ArticleTitleSingle-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra Urology 65 IssueID1 37–41 Occurrence Handle15667859

    PubMed  Google Scholar 

  • CP Smith P Radziszewski A Borkowski GT Somogyi TB Boone MB Chancellor (2004) ArticleTitleBotulinum toxin A has antinociceptive effects in treating interstitial cystitis Urology 64 IssueID5 871–875 Occurrence Handle15533466

    PubMed  Google Scholar 

  • GP Sui C Wu CH Fry (2004) ArticleTitleElectrical characteristics of suburothelial cells isolated from the human bladder J Urol 171 IssueID2 Pt 1 938–943 Occurrence Handle14713858 Occurrence Handle1:STN:280:DC%2BD2c%2Fhs1Ggug%3D%3D

    PubMed  CAS  Google Scholar 

  • Y Sun S Keay PG De Deyne TC Chai (2001) ArticleTitleAugmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis J Urol 166 IssueID5 1951–1956 Occurrence Handle11586266 Occurrence Handle1:CAS:528:DC%2BD3MXotVWls7s%3D

    PubMed  CAS  Google Scholar 

  • HV Tempest AK Dixon WH Turner S Elneil LA Sellers DR Ferguson (2004) ArticleTitleP2X2 and P2X3 receptor expression in human bladder urothelium and changes in interstitial cystitis BJU Int 93 1344–1348 Occurrence Handle15180635 Occurrence Handle1:CAS:528:DC%2BD2cXmt1ertLY%3D

    PubMed  CAS  Google Scholar 

  • DG Tincello AC Walker (2005) ArticleTitleInterstitial cystitis in the UK: results of a questionnaire survey of members of the interstitial cystitis support group Eur J Obstet Gynecol Reprod Biol 118 IssueID1 91–95 Occurrence Handle15596280

    PubMed  Google Scholar 

  • VM Vemulakonda GT Somogyi S Kiss NA Salas TB Boone CP Smith (2005) ArticleTitleInhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation J Urol 173 IssueID2 621–624 Occurrence Handle15643276 Occurrence Handle1:CAS:528:DC%2BD2MXitl2qug%3D%3D

    PubMed  CAS  Google Scholar 

  • M Vlaskovska L Kasakov W Rong P Bodin M Bardini DA Cockayne APDW Ford G Burnstock (2000) ArticleTitleP2X3 knock-out mice reveal a major sensory role for urothelially released ATP J Neurosci 21 IssueID15 5670–5677

    Google Scholar 

  • AJ Wein RR Rackley (2006) ArticleTitleOveractive bladder: a better understanding of pathophysiology, diagnosis and management J Urol 175 IssueID3 Pt 2 S5–S10 Occurrence Handle16458739

    PubMed  Google Scholar 

  • MJ Welch JR Purkiss KA Foster (2000) ArticleTitleSensitivity of embryonic rat dorsal root ganglia neurons to clostridium botulinum neurotoxins Toxicon 38 245–258 Occurrence Handle10665805 Occurrence Handle1:CAS:528:DyaK1MXns1Gqt7Y%3D

    PubMed  CAS  Google Scholar 

  • OJ Wiseman CJ Fowler DN Landon (2003) ArticleTitleThe role of the human bladder lamina propria myofibroblast BJU Int 91 89–93 Occurrence Handle12614258 Occurrence Handle1:STN:280:DC%2BD3s7gt1Wjtw%3D%3D

    PubMed  CAS  Google Scholar 

  • M Yoshida A Inadome K Masunaga Y Sugiyama M Otani H Iwashita K Miyamae S Ueda (2004a) ArticleTitleNon-neuronal acetylcholine and ATP releases from isolated normal and neurogenic human bladder Neurourol Urodyn 23 IssueID5/6 503–504 Occurrence Handle1:CAS:528:DC%2BD2cXns1Wguro%3D

    CAS  Google Scholar 

  • M Yoshida K Miyamae H Iwashita M Otani A Inadome (2004b) ArticleTitleManagement of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging Urology 63 IssueIDSuppl 3A 17–23

    Google Scholar 

  • N Yoshimura (1999) ArticleTitleBladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder Prog Neurobiol 57 583–606 Occurrence Handle10221783 Occurrence Handle1:STN:280:DyaK1M3js12ksA%3D%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Apostolidis.

Additional information

Correspondence: Apostolos Apostolidis, 2nd Department of Urology, Papageorgiou Hospital, Aristotle University of Thessaloniki, Ring Road, Nea Efkarpia, 56429 Thessaloniki, Greece

Rights and permissions

Reprints and permissions

About this article

Cite this article

Apostolidis, A., Fowler, C. The use of botulinum neurotoxin type A (BoNTA) in urology. J Neural Transm 115, 593–605 (2008). https://doi.org/10.1007/s00702-007-0862-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-007-0862-x

Navigation